Phase II Trial of Maintenance Rituximab Plus FavId and GM-CSF Immunotherapy in Patients With Treatment-Naive Indolent B-Cell Lymphoma
Phase of Trial: Phase II
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Mitumprotimut T; Rituximab
- Indications Non-Hodgkin's lymphoma
- Focus Therapeutic Use
- Sponsors MMRGlobal
- 27 Feb 2017 Last checked against ClinicalTrials.gov record 22 Sep 2008.
- 05 Jun 2007 Interim results reported at ASCO 2007.
- 14 Dec 2005 New trial record.